-
Most Recent
Search Results
240 results for CMED
CRVO Stock Earnings: CervoMed Misses EPS, Beats Revenue for Q4 2023
CRVO stock results show that CervoMed missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
RMD Stock Earnings: ResMed Beats EPS, Beats Revenue for Q3 2024
RMD stock results show that ResMed beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.
CRVO Stock Earnings: CervoMed Misses EPS, Beats Revenue for Q1 2024
CRVO stock results show that CervoMed missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
CRVO Stock Earnings: CervoMed Beats EPS, Beats Revenue for Q2 2024
CRVO stock results show that CervoMed beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
OBIO Stock Earnings: Orchestra BioMed Hldgs Misses EPS, Beats Revenue for Q2 2024
OBIO stock results show that Orchestra BioMed Hldgs missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
SMTI Stock Earnings: Sanara MedTech Misses EPS, Beats Revenue for Q2 2024
SMTI stock results show that Sanara MedTech missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
OBIO Stock Earnings: Orchestra BioMed Hldgs Beats EPS, Misses Revenue for Q4 2023
OBIO stock results show that Orchestra BioMed Hldgs beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
PETS Stock Earnings: PetMed Express Misses EPS, Beats Revenue for Q3 2024
PETS stock results show that PetMed Express missed analyst estimates for earnings per share but beat on revenue for the third quarter of 2024.
SMTI Stock Earnings: Sanara MedTech Misses EPS, Beats Revenue for Q1 2024
SMTI stock results show that Sanara MedTech missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
OBIO Stock Earnings: Orchestra BioMed Hldgs Beats EPS, Misses Revenue for Q1 2024
OBIO stock results show that Orchestra BioMed Hldgs beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
PETS Stock Earnings: PetMed Express Misses EPS, Misses Revenue for Q4 2024
PETS stock results show that PetMed Express missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2024.
SMTI Stock Earnings: Sanara MedTech Beats EPS, Beats Revenue for Q4 2023
SMTI stock results show that Sanara MedTech beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Medical Device Stocks: Buy, Sell and Watch
Medtronic’s Q4 earnings had medical device stocks buzzing this week. Take a look at which stocks to buy, sell and keep an eye on in…
What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.
So what did the stock market do today? All eyes were on Tesla stock as it set a new record and MNMD stock ahead of…
Trend Micro Layoffs 2024: What to Know About the Latest TMICY Job Cuts
Trend Micro layoffs have the Japanese cybersecurity company cutting 2% of its global workforce as part of its business transformation.
CRM Stock Alert: Baird Boosts Salesforce With New Upgrade
Salesforce stock is gaining on Thursday after shares of CRM got an upgrade and increased price target from Baird analysts.
CMND Stock Earnings: Clearmind Medicine Reported Results for Q2 2024
Clearmind Medicine just reported results for the second quarter of 2024.
PetMed Express Earnings: PETS Stock Soars 37% on Q2 Beat
PetMed Express (PETS) earnings for the pet pharmacy’s fiscal second quarter of 2019 have PETS stock taking off on Monday.
PETS Stock: 9 Things to Know About Short-Squeeze Play PetMed Express
Today, short squeeze interest is driving the stock prices of heavily shorted stocks such as PETS stock dramatically higher on high volume.
MMEDF Stock: Why Psychedelics Play MindMed Is Feeling Groovy Today
MindMed (MMEDF) stock is heading higher on Thursday following news of a partnership deal with Swiss startup MindShift Compounds AG.
Why Is Trxade Health (MEDS) Stock Up 230% Today?
Trxade Health stock is soaring higher on Tuesday with heavy trading of MEDS stock after announcing an asset sales agreement.
FDA Gives Medtronic PLC (MDT) OK for Fake Pancreas to Treat Diabetes
Medtronic (MDT) has been given approval by the U.S. Food and Drug Administration for its MiniMed 670G system to treat Type 1 Diabetes.
7 – 10 of 240 results
